甲状腺激素水平与膀癌的发病率和阶段之间的相关性
Jia Wang1,2, Lu Yang2, Shigang Du2
1The Second Clinical Medical College, Kunming Medical University, Kunming, China.
European journal of medical research
|March 28, 2025
概括
甲状腺激素水平,包括甲状腺激素 (TSH),三甲状腺素总量 (TT3) 和甲状腺素总量 (TT4),与膀癌 (BC) 发病率和阶段有关. 低甲状腺过氧化酶抗体 (TPOAb) 也可能表明BC风险较高.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 甲状腺激素 (THs) 在新陈代谢,生长和发育中起着至关重要的作用.
- THs在致癌过程中的潜在参与,特别是膀癌 (BC),需要进一步调查.
- 了解TH水平和BC之间的关系可能为治疗提供新的途径.
研究的目的:
- 研究甲状腺激素水平与膀癌发病率之间的关联.
- 检查甲状腺激素水平与膀癌的阶段 (NMIBC与MIBC) 之间的相关性.
主要方法:
- 一项队列研究涉及46名被诊断为BC患者和47名健康对照.
- 根据TNM分期,将BC患者分为非肌肉侵入性 (NMIBC) 和肌肉侵入性 (MIBC) 的分类.
- 测量甲状腺激素 (TSH,TT3,TT4) 和抗体 (TPOAb),然后进行统计分析.
主要成果:
- 与对照组相比,BC患者表现出更高的TSH,TT3,TT4和铁血球蛋白水平,以及较低的TPOAb.
- 与对照组相比,NMIBC和MIBC患者均显示TT3和TT4水平升高.
- 在TSH,TT3和TT4水平升高的组中观察到NMIBC和MIBC患者的比例更高.
结论:
- 升高的TSH,TT3,TT4和低的TPOAb水平与BC发病率和阶段的增加有关.
- 这些甲状腺参数可以作为评估BC预后的有用指标.
- 这些发现表明潜在的新治疗策略,针对BC的甲状腺激素途径.
更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
2.2K
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
2.1K
相关概念视频
Synthesis and Regulation of Thyroid Hormones
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
